Lefrère J-J
Département d'études des agents transmissibles par le sang, institut national de la transfusion sanguine, Paris, France.
Transfus Clin Biol. 2011 Aug;18(4):468-71. doi: 10.1016/j.tracli.2011.04.003. Epub 2011 Jul 28.
Pathogen reduction technology, now applicable to platelets and plasma, has limits that are already known, and potential or poorly defined other ones. We can distinguish limitations due to adverse events related to the technology itself or to recipient susceptibility, the limits of effectiveness depending on the target, the technology, organizational, economic and geographical limits.
病原体灭活技术目前已应用于血小板和血浆，其存在一些已知的局限性，以及其他潜在的或尚未明确界定的局限性。我们可以区分由于与该技术本身相关的不良事件或受者易感性导致的局限性、取决于目标的有效性局限性、技术局限性、组织局限性、经济局限性和地理局限性。
